The arthritis drug Vioxx was not fit for sale because it doubled the risk of heart attacks, a judge has found.
Federal Court judge Christopher Jessop awarded compensation on Friday to Graeme Peterson, who claimed the drug caused him to have a heart attack in 2003.
Mr Peterson sued US pharmaceutical giant Merck claiming he was no longer able to work because of the heart attack. On Friday Judge Jessop found Vioxx was "not of merchantable quality" and was not fit for the purpose of arthritic relief.
"I have concluded that across a population the consumption of Vioxx about doubled the risk of heart attack," Judge Jessop said.
"I have held that because Vioxx involved about a doubling of the risk of heart attack, it was not reasonably fit for the purpose of being used for the relief of arthritic pain."
News that makes sense
Your trusted source for staying up-to-date with the world around you. Get free daily news updates and analysis, straight to your inbox.
An amount of compensation will be determined at a later date.
